30-second summary:
Bioluminescence is assisting scientists in the development of drugs for treating brain cancer. Researchers are using a luciferase gene, which emits light, to visualize the treatment’s effectiveness when administered to live animals. This innovative technique allows researchers to monitor tumors’ growth and determine drug dosage. In addition, scientists are optimistic that this approach will reduce the time and cost of drug development. Brain cancer is a rare but deadly disease, and drug development is still in its early stages. This promising method may bring a new wave of treatments to cancer patients.
Click here for the full news:
scopeblog.stanford.edu
Trouble reading news?
Please right-click with the mouse (if you use touchscreen: long press ) on the link above, then select “Open in New Tab”.